95 related articles for article (PubMed ID: 8975942)
1. Chemoembolization and percutaneous ethanol injection for intrahepatic recurrence of hepatocellular carcinoma after hepatic resection.
Sato M; Watanabe Y; Iseki N; Ueda S; Kawach K; Kimura S; Itoh Y; Ohkubo K; Onji M
Hepatogastroenterology; 1996; 43(12):1421-6. PubMed ID: 8975942
[TBL] [Abstract][Full Text] [Related]
2. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.
Tralhão JG; Dagher I; Lino T; Roudié J; Franco D
Eur J Surg Oncol; 2007 Aug; 33(6):746-51. PubMed ID: 17188454
[TBL] [Abstract][Full Text] [Related]
3. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
[TBL] [Abstract][Full Text] [Related]
4. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.
Horigome H; Nomura T; Nakao H; Saso K; Takahashi Y; Akita S; Sobue S; Mizuno Y; Nojiri S; Hirose A; Masuko K; Murasaki G; Fujino N; Nakahara R; Ichikawa T; Itoh M
Hepatogastroenterology; 2000; 47(32):507-11. PubMed ID: 10791223
[TBL] [Abstract][Full Text] [Related]
5. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.
Troisi R; Defreyne L; Hesse UJ; Praet M; Decruyenaere J; De Hemptinne B
Clin Transplant; 1998 Aug; 12(4):313-9. PubMed ID: 9686325
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
7. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching.
Cho YB; Lee KU; Suh KS; Kim YJ; Yoon JH; Lee HS; Hahn S; Park BJ
J Gastroenterol Hepatol; 2007 Oct; 22(10):1643-9. PubMed ID: 17845692
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of transarterial embolization combined with percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma].
Shimamura T; Une Y; Nakajima Y; Sato N; Matsushita M; Kamiyama T; Uchino J
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2229-32. PubMed ID: 7944447
[TBL] [Abstract][Full Text] [Related]
13. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H
Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716
[TBL] [Abstract][Full Text] [Related]
15. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
17. [SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma].
Numata K; Tanaka K; Kiba T; Saito S; Morita K; Kitamura T; Kondo M; Morimoto M; Shirato K; Hori A; Shimamura T; Isozaki T; Arata S; Okazaki H; Fujii T; Sekihara H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():141-5. PubMed ID: 9512702
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Miyazaki I
Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
[TBL] [Abstract][Full Text] [Related]
19. Postoperative recurrence of solitary small hepatocellular carcinoma.
Ezaki T; Koyanagi N; Yamagata M; Kajiyama K; Maeda T; Sugimachi K
J Surg Oncol; 1996 Jun; 62(2):115-22. PubMed ID: 8649037
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
